These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22549186)

  • 21. Differentiation of human mesenchymal stem cells: the potential mechanism for estrogen-induced preferential osteoblast versus adipocyte differentiation.
    Zhao JW; Gao ZL; Mei H; Li YL; Wang Y
    Am J Med Sci; 2011 Jun; 341(6):460-8. PubMed ID: 21289500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
    Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
    J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation.
    Kühn MC; Willenberg HS; Schott M; Papewalis C; Stumpf U; Flohé S; Scherbaum WA; Schinner S
    Mol Cell Endocrinol; 2012 Feb; 349(2):180-8. PubMed ID: 22040599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of differentiating embryonic stem cells in pharmacological studies.
    Wdziekonski B; Villageois P; Vernochet C; Phillips B; Dani C
    Methods Mol Biol; 2006; 329():341-51. PubMed ID: 16846003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA interference of PPARgamma using fiber-modified adenovirus vector efficiently suppresses preadipocyte-to-adipocyte differentiation in 3T3-L1 cells.
    Hosono T; Mizuguchi H; Katayama K; Koizumi N; Kawabata K; Yamaguchi T; Nakagawa S; Watanabe Y; Mayumi T; Hayakawa T
    Gene; 2005 Mar; 348():157-65. PubMed ID: 15777692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New factors controlling the balance between osteoblastogenesis and adipogenesis.
    Abdallah BM; Kassem M
    Bone; 2012 Feb; 50(2):540-5. PubMed ID: 21745614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPARgamma in adipocyte differentiation and metabolism--novel insights from genome-wide studies.
    Siersbaek R; Nielsen R; Mandrup S
    FEBS Lett; 2010 Aug; 584(15):3242-9. PubMed ID: 20542036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPAR gamma: ally and foe in bone metabolism.
    Wahli W
    Cell Metab; 2008 Mar; 7(3):188-90. PubMed ID: 18316021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
    Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
    Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poncirin promotes osteoblast differentiation but inhibits adipocyte differentiation in mesenchymal stem cells.
    Yoon HY; Yun SI; Kim BY; Jin Q; Woo ER; Jeong SY; Chung YS
    Eur J Pharmacol; 2011 Aug; 664(1-3):54-9. PubMed ID: 21550337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between bone metabolism and adipogenesis].
    Nishimura R; Hata K; Yoneda T
    Clin Calcium; 2007 Feb; 17(2):233-40. PubMed ID: 17272881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations.
    Taipaleenmäki H; Abdallah BM; AlDahmash A; Säämänen AM; Kassem M
    Exp Cell Res; 2011 Apr; 317(6):745-56. PubMed ID: 21211534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of PPAR gamma for the osteoblastic differentiation].
    Takeda S; Takeuchi Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():789-93. PubMed ID: 15035228
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of cyclooxygenase-2 down-regulates osteoclast and osteoblast differentiation and favours adipocyte formation in vitro.
    Kellinsalmi M; Parikka V; Risteli J; Hentunen T; Leskelä HV; Lehtonen S; Selander K; Väänänen K; Lehenkari P
    Eur J Pharmacol; 2007 Oct; 572(2-3):102-10. PubMed ID: 17632097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of ZNF395 as a novel modulator of adipogenesis.
    Hasegawa R; Tomaru Y; de Hoon M; Suzuki H; Hayashizaki Y; Shin JW
    Exp Cell Res; 2013 Feb; 319(3):68-76. PubMed ID: 23142027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation.
    Shin DW; Kim SN; Lee SM; Lee W; Song MJ; Park SM; Lee TR; Baik JH; Kim HK; Hong JH; Noh M
    Biochem Pharmacol; 2009 Jan; 77(1):125-33. PubMed ID: 18951882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin and osteocalcin: relation to insulin sensitivity.
    Zhang Y; Zhou P; Kimondo JW
    Biochem Cell Biol; 2012 Oct; 90(5):613-20. PubMed ID: 22812431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis.
    Takada I; Kouzmenko AP; Kato S
    Nat Rev Rheumatol; 2009 Aug; 5(8):442-7. PubMed ID: 19581903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gata2 Is a Rheostat for Mesenchymal Stem Cell Fate in Male Mice.
    Li X; Huynh H; Zuo H; Salminen M; Wan Y
    Endocrinology; 2016 Mar; 157(3):1021-8. PubMed ID: 26812161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erucic acid derived from rosemary regulates differentiation of mesenchymal stem cells into osteoblasts/adipocytes via suppression of peroxisome proliferator-activated receptor γ transcriptional activity.
    Takahashi A; Dohi H; Egashira Y; Hirai S
    Phytother Res; 2020 Jun; 34(6):1358-1366. PubMed ID: 31989712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.